These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 23788720

  • 81.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 82.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 83.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 84. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study.
    Bosak M, Sułek A, Łukasik M, Żak A, Słowik A, Lasek-Bal A.
    Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378
    [Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87. The epilepsy, the protease inhibitor and the dodecamer: progressive myoclonus epilepsy, cystatin b and a 12-mer repeat expansion.
    Lalioti MD, Antonarakis SE, Scott HS.
    Cytogenet Genome Res; 2003 Nov; 100(1-4):213-23. PubMed ID: 14526183
    [Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Lehesjoki AE, Koskiniemi M.
    Epilepsia; 1999 Nov; 40 Suppl 3():23-8. PubMed ID: 10446747
    [Abstract] [Full Text] [Related]

  • 91. Quantitative Changes in the Mitochondrial Proteome of Cerebellar Synaptosomes From Preclinical Cystatin B-Deficient Mice.
    Gorski K, Spoljaric A, Nyman TA, Kaila K, Battersby BJ, Lehesjoki AE.
    Front Mol Neurosci; 2020 Nov; 13():570640. PubMed ID: 33281550
    [Abstract] [Full Text] [Related]

  • 92. Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1).
    Äikiä M, Hyppönen J, Mervaala E, Kälviäinen R.
    Epilepsy Behav; 2021 Sep; 122():108157. PubMed ID: 34171687
    [Abstract] [Full Text] [Related]

  • 93.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95. Influence of partial unfolding and aggregation of human stefin B (cystatin B) EPM1 mutants G50E and Q71P on selective cleavages by cathepsins B and S.
    Polajnar M, Vidmar R, Vizovišek M, Fonović M, Kopitar-Jerala N, Žerovnik E.
    Biol Chem; 2013 Jun; 394(6):783-90. PubMed ID: 23362198
    [Abstract] [Full Text] [Related]

  • 96. Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B.
    Chan EM, Andrade DM, Franceschetti S, Minassian B.
    Adv Neurol; 2005 Jun; 95():47-57. PubMed ID: 15508913
    [No Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99. Clinical and molecular characterization of Unverricht-Lundborg disease among Egyptian patients.
    Hosny H, El Tamawy M, Gouider R, Lesca G, Abdel Naseer M, Kishk N, Abdel-Hamid MS, Ashmawi A.
    Epilepsy Res; 2021 Oct; 176():106746. PubMed ID: 34474241
    [Abstract] [Full Text] [Related]

  • 100. Coexistence of Unverricht-Lundborg disease and congenital deafness: molecular resolution of a complex comorbidity.
    Kecmanović M, Ristić AJ, Sokić D, Keckarević-Marković M, Vojvodić N, Ercegovac M, Janković S, Keckarević D, Savić-Pavićević D, Romac S.
    Epilepsia; 2009 Jun; 50(6):1612-5. PubMed ID: 19170735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.